Dialysis-related amyloidosis is a freequent complication encountered in patients receiving long-term haemodialysis. This book presents evidence on the possible role of beta2-microglobulin modified with advanced glycation end products (AGE) in the pathogenesis of the disease. The first of the three sections investigates the structure of AGE-modified protein, its formation mechanisms and its biological activity. The book reveals that AGE-modified beta2-microglobulin has a chemotactic effect on monocytes, and stimulates macrophages to secrete interleuken 1beta, interleuken 6 and TNFalpha. In other sections, the factors causing dialysis related amyloidosis are examined and the effectiveness of various haemo-purification methods in alleviating osteoarthropathy are assessed.
FREE Two-Day Shipping for Students. Learn more |
Book Description
Special Offers and Product Promotions
- Buy $50 in qualifying physical textbooks, get $5 in Amazon MP3 Credit. Here's how (restrictions apply)
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
